BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Regulation of signal transducer and activator of transcription 3 activation by dual-specificity phosphatase 3

  • Kim, Ba Reum (Laboratory of Molecular and Pharmacological Cell Biology, College of Pharmacy, Chung-Ang University) ;
  • Ha, Jain (Laboratory of Molecular and Pharmacological Cell Biology, College of Pharmacy, Chung-Ang University) ;
  • Kang, Eunjeong (Laboratory of Molecular and Pharmacological Cell Biology, College of Pharmacy, Chung-Ang University) ;
  • Cho, Sayeon (Laboratory of Molecular and Pharmacological Cell Biology, College of Pharmacy, Chung-Ang University)
  • Received : 2020.03.15
  • Accepted : 2020.05.26
  • Published : 2020.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Since cancer is the leading cause of death worldwide, there is an urgent need to understand the mechanisms underlying cancer progression and the development of cancer inhibitors. Signal transducer and activator of transcription 3 (STAT3) is a major transcription factor that regulates the proliferation and survival of various cancer cells. Here, dual-specificity phosphatase 3 (DUSP3) was identified as a regulator of STAT3 based on an interaction screening performed using the protein tyrosine phosphatase library. DUSP3 interacted with the C-terminal domain of STAT3 and dephosphorylated p-Y705 of STAT3. In vitro dephosphorylation assay revealed that DUSP3 directly dephosphorylated p-STAT3. The suppressive effects of DUSP3 on STAT3 were evaluated by a decreased STAT3-specific promoter activity, which in turn reduced the expression of the downstream target genes of STAT3. In summary, DUSP3 downregulated the transcriptional activity of STAT3 via dephosphorylation at Y705 and also suppressed the migratory activity of cancer cells. This study demonstrated that DUSP3 inhibits interleukin 6 (IL-6)/STAT3 signaling and is expected to regulate cancer development. Novel functions of DUSP3 discovered in IL-6/STAT3 signaling regulation would help expand the understanding of cancer development mechanisms.

Keywords

References

  1. Multhoff G, Molls M and Radons J (2011) Chronic Inflammation in Cancer Development. Front Immunol 2, Article 98
  2. DeNardo DG, Johansson M and Coussens LM (2008) Immune Cells as Mediators of Solid Tumor Metastasis. Cancer Metastasis Rev 27, 11-18 https://doi.org/10.1007/s10555-007-9100-0
  3. Lee H, Jeong AJ and Ye SK (2019) Highlighted STAT3 as a potential drug target for cancer therapy. BMB Rep 52, 415-423 https://doi.org/10.5483/bmbrep.2019.52.7.152
  4. Darnell JE (1997) STATs and Gene Regulation. Science 277, 1630-1635 https://doi.org/10.1126/science.277.5332.1630
  5. Park Y and Kim J (2019) Regulation of IL-6 signaling by miR-125a and let-7e in endothelial cells controls vasculogenic mimicry formation of breast cancer cells. BMB Rep 52, 214-219 https://doi.org/10.5483/bmbrep.2019.52.3.308
  6. Inoue H, Ogawa W, Ozaki M et al (2004) Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat Med 10, 168-174 https://doi.org/10.1038/nm980
  7. Yu H and Jove R (2004) The STATs of Cancer-New Molecular Targets Come of Age. Nat Rev Cancer 4, 97-105 https://doi.org/10.1038/nrc1275
  8. Demaria M, Giorgi C, Lebiedzinska M et al (2010) A STAT3-Mediated Metabolic Switch is Involved in Tumour Transformation and STAT3 Addiction. Aging (Albany NY) 2, 823-842 https://doi.org/10.18632/aging.100232
  9. Li J, Liu T, Zhao L et al (2015) Ginsenoside 20 (S)-Rg3 Inhibits the Warburg Effect through STAT3 Pathways in Ovarian Cancer Cells. Int J Oncol 46, 775-781 https://doi.org/10.3892/ijo.2014.2767
  10. Svinka J, Mikulits W and Eferl R (2014) STAT3 in hepatocellular carcinoma: new perspectives. Hepat Oncol 1, 107-120 https://doi.org/10.2217/hep.13.7
  11. Lee S, Lee M, Kim JB et al (2016) 17beta-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling. Biochem Biophys Res Commun 473, 1247-1254 https://doi.org/10.1016/j.bbrc.2016.04.049
  12. Kim M, Morales L, Jang IS, Cho YY and Kim D (2018) Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling. Int J Mol Sci 19, E2708
  13. Sekine Y, Tsuji S, Ikeda O et al (2006) Regulation of STAT3-Mediated Signaling by LMW-DSP2. Oncogene 25, 5801-5806 https://doi.org/10.1038/sj.onc.1209578
  14. Hou J, Xu J, Jiang R et al (2013) Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3. Hepatology 57, 678-688 https://doi.org/10.1002/hep.25980
  15. Ishibashi T, Bottaro DP, Chan A, Miki T and Aaronson SA (1992) Expression Cloning of a Human Dual-Specificity Phosphatase. Proc Natl Acad Sci U S A 89, 12170-12174 https://doi.org/10.1073/pnas.89.24.12170
  16. Wang JY, Yeh CL, Chou HC et al (2011) Vaccinia H1-Related Phosphatase (VHR) is a Phosphatase of ErbB Receptors and is Down-Regulated in Non-Small Cell lung Cancer. J Biol Chem 286, 10177-10184 https://doi.org/10.1074/jbc.M110.163295
  17. Todd JL, Rigas JD, Rafty LA and Denu JM (2002) Dual-Specificity Protein Tyrosine Phosphatase VHR Down-Regulates c-Jun N-terminal Kinase (JNK). Oncogene 21, 2573-2583 https://doi.org/10.1038/sj.onc.1205344
  18. Todd JL, Tanner KG and Denu JM (1999) Extracellular Regulated Kinases (ERK) 1 and ERK2 are Authentic Substrates for the Dual-Specificity Protein-Tyrosine Phosphatase VHR. A Aovel Role in Down-Regulating the ERK Pathway. J Biol Chem 274, 13271-13280 https://doi.org/10.1074/jbc.274.19.13271
  19. Liu L, McBride KM and Reich NC (2005) STAT3 Nuclear Import is Independent of Tyrosine Phosphorylation and Mediated by Importin-${\alpha}3$. Proc Natl Acad Sci U S A 102, 8150-8155 https://doi.org/10.1073/pnas.0501643102
  20. Bromberg J and Wang TC (2009) Inflammation and Cancer: IL-6 and STAT3 Complete the Link. Cancer Cell 15, 79-80 https://doi.org/10.1016/j.ccr.2009.01.009
  21. Kumar J, Fraser F, Riley C, Ahmed N, McCulloch D and Ward A (2015) Granulocyte Colony-Stimulating Factor Receptor Signalling via Janus Kinase 2/Signal Transducer and Activator of Transcription 3 in Ovarian Cancer. Br J Cancer 113, 1642-1643
  22. Puente XS, Pinyol M, Quesada V et al (2011) Whole-Genome Sequencing Identifies Recurrent Mutations in Chronic Lymphocytic Leukaemia. Nature 475, 101-105 https://doi.org/10.1038/nature10113
  23. Devarajan E and Huang S (2009) STAT3 as a Central Regulator of Tumor Metastases. Curr Mol Med 9, 626-633 https://doi.org/10.2174/156652409788488720
  24. Hoyt R, Zhu W, Cerignoli F, Alonso A, Mustelin T and David M (2007) Cutting Edge: Selective Tyrosine Dephosphorylation of Interferon-Activated Nuclear STAT5 by the VHR Phosphatase. J Immunol 179, 3402-3406 https://doi.org/10.4049/jimmunol.179.6.3402
  25. Stahl N, Boulton TG, Farruggella T et al (1994) Association and Activation of Jak-Tyk Kinases by CNTF-LIFOSM- IL-6 Beta Receptor Components. Science 263, 92-95 https://doi.org/10.1126/science.8272873
  26. Han Y, Amin HM, Franko B, Frantz C, Shi X and Lai R (2006) Loss of SHP1 Enhances JAK3/STAT3 Signaling and Decreases Proteosome Degradation of JAK3 and NPM-ALK in ALK+ Anaplastic Large-Cell Lymphoma. Blood 108, 2796-2803
  27. Li C and Friedman JM (1999) Leptin Receptor Activation of SH2 Domain Containing Protein Tyrosine Phosphatase 2 Modulates Ob Receptor SignalTtransduction. Proc Natl Acad Sci U S A 96, 9677-9682 https://doi.org/10.1073/pnas.96.17.9677
  28. Wakahara R, Kunimoto H, Tanino K et al (2012) Phospho-Ser727 of STAT3 Regulates STAT3 Activity by Enhancing Dephosphorylation of Phospho-Tyr705 Largely through TC45. Genes Cells 17, 132-145 https://doi.org/10.1111/j.1365-2443.2011.01575.x
  29. Veeriah S, Brennan C, Meng S et al (2009) The Tyrosine Phosphatase PTPRD is a Tumor Suppressor that is Frequently Inactivated and Mutated in Glioblastoma and Other Human Cancers. Proc Natl Acad Sci U S A 106, 9435-9440 https://doi.org/10.1073/pnas.0900571106
  30. Zhang X, Guo A, Yu J et al (2007) Identification of STAT3 as a Substrate of Receptor Protein Tyrosine Phosphatase T. Proc Natl Acad Sci U S A 104, 4060-4064 https://doi.org/10.1073/pnas.0611665104
  31. Chen YW, Guo T, Shen L et al (2015) Receptor-Type Tyrosine-Protein Phosphatase Kappa Directly Targets STAT3 Activation for Tumor Suppression in Nasal NK/T-Cell Lymphoma. Blood 125, 1589-1600 https://doi.org/10.1182/blood-2014-07-588970
  32. Alonso A, Sasin J, Bottini N et al (2004) Protein tyrosine phosphatases in the human genome. Cell 117, 699-711 https://doi.org/10.1016/j.cell.2004.05.018
  33. Bourdeau A, Dube N and Tremblay ML (2005) Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. Curr Opin Cell Biol 17, 203-209 https://doi.org/10.1016/j.ceb.2005.02.001
  34. Lee H, Morales LD, Slaga TJ and Kim DJ (2015) Activation of T-cell protein-tyrosine phosphatase suppresses keratinocyte survival and proliferation following UVB irradiation. J Biol Chem 290, 13-24 https://doi.org/10.1074/jbc.M114.611681
  35. Pavic K, Duan G and Kohn M (2015) VHR/DUSP3 Phosphatase: Structure, Function and Regulation. FEBS J 282, 1871-1890 https://doi.org/10.1111/febs.13263
  36. Vandereyken M, Jacques S, Van Overmeire E et al (2017) Dusp3 Deletion in Mice Promotes Experimental Lung Tumour Metastasis in a Macrophage Dependent Manner. PLoS One 12, e0185786 https://doi.org/10.1371/journal.pone.0185786
  37. Singh P, Dejager L, Amand M et al (2015) DUSP3 Genetic Deletion Confers M2-Like Macrophage-Dependent Tolerance to Septic Shock. J Immunol 194, 4951-4962 https://doi.org/10.4049/jimmunol.1402431
  38. Takaishi K, Komohara Y, Tashiro H et al (2010) Involvement of M2-Polarized Macrophages in the Ascites from Advanced Epithelial Ovarian Carcinoma in Tumor Progression via Stat3 Activation. Cancer Sci 101, 2128-2136 https://doi.org/10.1111/j.1349-7006.2010.01652.x
  39. Shiraishi D, Fujiwara Y, Komohara Y, Mizuta H and Takeya M (2012) Glucagon-Like Peptide-1 (GLP-1) Induces M2 Polarization of Human Macrophages via STAT3 Activation. Biochem Biophys Res Commun 425, 304-308 https://doi.org/10.1016/j.bbrc.2012.07.086
  40. Perovic V, Sumonja N, Gemovic B, Toska E, Roberts SG and Veljkovic N (2017) TRI_Tool: a Web-Tool for Prediction of Protein-Protein Interactions in Human Transcriptional Regulation. Bioinformatics 33, 289-291 https://doi.org/10.1093/bioinformatics/btw590